We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$54.7B
AUM Growth
+$1.45B
Cap. Flow
+$1.02B
Cap. Flow %
1.86%
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$65.3M
2
GPN icon
Global Payments
GPN
+$40.3M
3
MSFT icon
Microsoft
MSFT
+$37.9M
4
LHX icon
L3Harris
LHX
+$32.8M
5
AMZN icon
Amazon
AMZN
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 18.64%
2 Financials 15.56%
3 Healthcare 12.85%
4 Consumer Discretionary 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGW
1226
DELISTED
Calavo Growers
CVGW
$4.66M 0.01%
48,925
+2,076
+4% +$191K
SFBS
1227
ServisFirst Bancshares
SFBS
$4.94B
$4.66M 0.01%
140,418
+3,265
+2% +$105K
KRG icon
1228
Kite Realty
KRG
$5.56B
$4.62M 0.01%
286,216
+16,919
+6% +$259K
CTB
1229
DELISTED
Cooper Tire & Rubber Co.
CTB
$4.62M 0.01%
176,958
+10,404
+6% +$276K
CHGG icon
1230
Chegg
CHGG
$115M
$4.62M 0.01%
154,125
-6,828
-4% -$271K
CNX icon
1231
CNX Resources
CNX
$5.11B
$4.6M 0.01%
634,161
+1,649
+0.3% +$12.3K
COKE icon
1232
Coca-Cola Consolidated
COKE
$12.3B
$4.6M 0.01%
151,520
+3,660
+2% +$114K
AXS icon
1233
AXIS Capital
AXS
$7.61B
$4.59M 0.01%
68,843
+2,161
+3% +$136K
AWI icon
1234
Armstrong World Industries
AWI
$7.86B
$4.58M 0.01%
47,414
+52
+0.1% +$5.01K
HHH icon
1235
Howard Hughes
HHH
$3.92B
$4.57M 0.01%
37,022
+242
+0.7% +$29.9K
ONCE
1236
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$4.57M 0.01%
47,081
-2,266
-5% -$227K
NP
1237
DELISTED
Neenah, Inc. Common Stock
NP
$4.56M 0.01%
69,980
+3,782
+6% +$246K
SKT icon
1238
Tanger
SKT
$4.66B
$4.55M 0.01%
293,980
-1,746
-0.6% -$27.3K
ORA icon
1239
Ormat Technologies
ORA
$6.02B
$4.54M 0.01%
61,137
+3,571
+6% +$246K
JRVR icon
1240
James River Group Holdings
JRVR
$217M
$4.54M 0.01%
88,627
+4,185
+5% +$204K
MSGS icon
1241
Madison Square Garden
MSGS
$9.42B
$4.54M 0.01%
24,151
+346
+1% +$67.8K
TNDM icon
1242
Tandem Diabetes Care
TNDM
$1.34B
$4.52M 0.01%
76,564
-1,237
-2% -$79K
FORM icon
1243
FormFactor
FORM
$8.92B
$4.51M 0.01%
241,911
+15,452
+7% +$264K
NVRI icon
1244
Enviri
NVRI
$647M
$4.51M 0.01%
237,665
+1,991
+0.8% +$42.2K
ZWS icon
1245
Zurn Elkay Water Solutions
ZWS
$8.75B
$4.48M 0.01%
343,948
+20,489
+6% +$274K
CMPR icon
1246
Cimpress
CMPR
$2.44B
$4.47M 0.01%
33,931
-2,687
-7% -$296K
KYNB
1247
Kyntra Bio
KYNB
$28.3M
$4.47M 0.01%
4,838
-92
-2% -$101K
BERY
1248
DELISTED
Berry Global Group, Inc.
BERY
$4.46M 0.01%
123,590
+259
+0.2% +$10.6K
DK icon
1249
Delek US
DK
$3.66B
$4.45M 0.01%
122,616
+1,978
+2% +$72.8K
FCF icon
1250
First Commonwealth Financial
FCF
$2.19B
$4.45M 0.01%
335,044
+19,809
+6% +$257K

Similar funds

RhumbLine Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
  • RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
  • RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
  • RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
  • RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
  • RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.

Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.